Clinical Guidelines for Aciclovir During Pregnancy
MHRA Classification and Safety Profile
The Medicines and Healthcare products Regulatory Agency (MHRA) classifies aciclovir as pregnancy category B. This classification indicates that animal studies have not demonstrated adverse effects on the foetus, and whilst adequate human studies are limited, available data suggests aciclovir does not increase the risk of birth defects when used during pregnancy.
Oral Aciclovir in Pregnancy
Aciclovir 400mg tablets may be prescribed during pregnancy when treating severe or recurrent herpes infections, including cold sores. The medication crosses the placental barrier, but extensive pregnancy registries have not identified increased rates of congenital abnormalities. Treatment is typically recommended when the clinical benefits of controlling viral infection outweigh potential risks.
Topical Aciclovir During Pregnancy
Aciclovir 5% cream is generally considered the safer option during pregnancy due to minimal systemic absorption. When applied to cold sores around the mouth, only small amounts enter the bloodstream, making it the preferred first-line treatment for pregnant women experiencing mild to moderate outbreaks.
Clinical Considerations
Healthcare providers typically recommend starting aciclovir treatment early in a cold sore outbreak for maximum effectiveness. During pregnancy, this remains important as untreated herpes infections can potentially cause more complications than the medication itself. The standard treatment course involves taking aciclovir tablets five times daily for five days, though dosing may be adjusted based on individual circumstances.
Available Treatment Options
EverydayMeds stocks various aciclovir formulations suitable for pregnant women, including aciclovir 400mg tablets for systemic treatment and aciclovir cream for topical application. Valaciclovir 500mg tablets represent an alternative antiviral option with similar safety profiles during pregnancy, though aciclovir remains the most widely prescribed due to extensive safety data.
